SYNABS

Company in Belgium

Claim this Profile

Share this profile

Resume
Generating highly specific therapeutic and r&d monoclonal antibodies targeting haptens, gpcr, complex transmembrane proteins and difficult antigens
Social Network

Contact
Explore Company Now

  last updated on October 21st, 2024